Mark Bennett has become general manager for Asia Pacific of Newcastle upon Tyne, UK-based Nonlinear Dynamics, replacing Alan Koontz, who died last year. Bennett will retain his title and strategic management duties as CEO of Nonlinear’s US subsidiary, Nonlinear USA.
Ronald Lindsay has joined the board of directors of AnVil, based in Burlington, Mass. He is currently CSO and vice president of R&D at DiaDexus of San Francisco. Prior to that, he was senior vice president for biotherapeutics at Millennium Pharmaceuticals. Before that, he held positions at Regeneron, the
Sandoz Institute for Medical Research at University College
, London, and the National Institute of Medical Research in Mill Hill, London.
Vincent Forlenza has been appointed president of BD Biosciences, based in San Jose, Calif. Most recently, he was the company’s senior vice president for technology, strategy, and development. Forlenza succeeds Deborah Neff, who is leaving BD to pursue other opportunities. He holds a BS in chemical engineering from Lehigh University and an MBA from the Wharton Graduate School at the University of Pennsylvania.